Figure 1From: The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi Proportion of patients who experienced episodes of hepatoxicity of any grade (Panel A) or hepatoxicity of grade ≥ 2 (Panel B) by infection group. Back to article page